Overview Akebia Therapeutics, a biopharmaceutical company based in Cambridge, Massachusets, has announced that the U.S. Food and Drug Administration (FDA) has acknowledged the ...

Fulcrum Therapeutics experienced a significant boost in stock value as the U.S. Food and Drug Administration (FDA) lifted the clinical hold on their ...

Shares of Regeneron Pharmaceuticals Inc. (REGN) gained 1.4% in premarket trading on Monday, following the company’s announcement late Friday that the U.S. Food ...